Delving into the Latest Updates on Cedona Pharmaceuticals BV with Synapse

Overview

AbstractThe aim of the present study was to evaluate the bioavailability of a new tablet formulation of carbocysteine relative against two other oral carbocysteine containing dosage forms, viz. a syrup and capsules. Plasma levels and urine concentrations of carbocysteine were monitored, following oral administration of all three dosage forms to healthy human volunteers, by direct derivatization of carbocysteine using dabsylchloride and subsequent high performance liquid chromatography.There was no difference in bioavailability of carbocysteine from these dosage forms as expressed by the respective areas under the plasma concentration‐time curves and total amounts of unchanged carbocysteine excreted in urine.

100 Deals associated with Cedona Pharmaceuticals BV

Login to view more data

100 Translational Medicine associated with Cedona Pharmaceuticals BV

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 18 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

2

Login to view more data